Literature DB >> 22649204

CD8+ T cells suppress viral replication in the cornea but contribute to VEGF-C-induced lymphatic vessel genesis.

Christopher D Conrady1, Min Zheng, Donald U Stone, Daniel J J Carr.   

Abstract

HSV-1 is the leading cause of infectious corneal blindness in the industrialized world. CD4(+) T cells are thought to be the major leukocyte population mediating immunity to HSV-1 in the cornea as well as the likely source of immunopathology that reduces visual acuity. However, the role of CD8(+) T cells in immune surveillance of the cornea is unclear. Thus, we sought to evaluate the role of CD8(+) T cells in ocular immunity using transgenic mice in which >98% of CD8(+) T cells are specific for the immunodominant HSV-1 epitope (gBT-I.1). We found a significant reduction in virus, elevation in HSV-specific CD8(+) T cell influx, and more CD8(+) T cells expressing CXCR3 in the cornea of transgenic mice compared with those in the cornea of wild-type controls yet similar acute corneal pathology. However, by day 30 postinfection, wild-type mice had drastically more blood and lymphatic vessel projections into the cornea compared with gBT-I.1 mice, in which only lymphatic vessel growth in response to VEGF-C could be appreciated. Taken together, these results show that CD8(+) T cells are required to eliminate virus more efficiently from the cornea but play a minimal role in immunopathology as a source of VEGF-C.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22649204      PMCID: PMC3382000          DOI: 10.4049/jimmunol.1200063

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  47 in total

1.  Penetrating keratoplasty for herpes simplex keratitis and keratoconus. Allograft rejection and survival.

Authors:  R J Epstein; J A Seedor; N G Dreizen; R D Stulting; G O Waring; L A Wilson; H D Cavanagh
Journal:  Ophthalmology       Date:  1987-08       Impact factor: 12.079

2.  T cell-macrophage interaction in arginase-mediated resistance to herpes simplex virus.

Authors:  L Bonina; A A Nash; A Arena; K N Leung; P Wildy
Journal:  Virus Res       Date:  1984-09       Impact factor: 3.303

3.  Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States.

Authors:  Fujie Xu; Maya R Sternberg; Benny J Kottiri; Geraldine M McQuillan; Francis K Lee; Andre J Nahmias; Stuart M Berman; Lauri E Markowitz
Journal:  JAMA       Date:  2006-08-23       Impact factor: 56.272

4.  Loss of the type I interferon pathway increases vulnerability of mice to genital herpes simplex virus 2 infection.

Authors:  Christopher D Conrady; William P Halford; Daniel J J Carr
Journal:  J Virol       Date:  2010-12-08       Impact factor: 5.103

5.  Both CD4+ and CD8+ T cells are involved in protection against HSV-1 induced corneal scarring.

Authors:  H Ghiasi; S Cai; G C Perng; A B Nesburn; S L Wechsler
Journal:  Br J Ophthalmol       Date:  2000-04       Impact factor: 4.638

6.  Role of MIP-2 in neutrophil migration and tissue injury in the herpes simplex virus-1-infected cornea.

Authors:  X T Yan; T M Tumpey; S L Kunkel; J E Oakes; R N Lausch
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-09       Impact factor: 4.799

7.  Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice.

Authors:  Mark D Wareing; Ashley B Lyon; Bao Lu; Craig Gerard; Sally R Sarawar
Journal:  J Leukoc Biol       Date:  2004-07-07       Impact factor: 4.962

8.  Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands.

Authors:  Marco Wendel; Ioanna E Galani; Elisabeth Suri-Payer; Adelheid Cerwenka
Journal:  Cancer Res       Date:  2008-10-15       Impact factor: 12.701

9.  CXCR3 deficiency increases susceptibility to genital herpes simplex virus type 2 infection: Uncoupling of CD8+ T-cell effector function but not migration.

Authors:  Manoj Thapa; Daniel J J Carr
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

10.  CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help.

Authors:  Yusuke Nakanishi; Bao Lu; Craig Gerard; Akiko Iwasaki
Journal:  Nature       Date:  2009-11-08       Impact factor: 49.962

View more
  33 in total

1.  Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.

Authors:  Arif A Khan; Ruchi Srivastava; Aziz A Chentoufi; Roger Geertsema; Nhi Thi Uyen Thai; Gargi Dasgupta; Nelson Osorio; Mina Kalantari; Anthony B Nesburn; Steven L Wechsler; Lbachir BenMohamed
Journal:  J Virol       Date:  2015-07       Impact factor: 5.103

2.  Resident T Cells Are Unable To Control Herpes Simplex Virus-1 Activity in the Brain Ependymal Region during Latency.

Authors:  Chandra M Menendez; Jeremy K Jinkins; Daniel J J Carr
Journal:  J Immunol       Date:  2016-06-29       Impact factor: 5.422

3.  CXCL1 but not IL-6 is required for recurrent herpetic stromal keratitis.

Authors:  Devin M West; Chelsea R Del Rosso; Xiao-Tang Yin; Patrick M Stuart
Journal:  J Immunol       Date:  2014-01-17       Impact factor: 5.422

4.  Prior Corneal Scarification and Injection of Immune Serum are Not Required Before Ocular HSV-1 Infection for UV-B-Induced Virus Reactivation and Recurrent Herpetic Corneal Disease in Latently Infected Mice.

Authors:  Lbachir BenMohamed; Nelson Osorio; Arif A Khan; Ruchi Srivastava; Lei Huang; John J Krochmal; Jairo M Garcia; Jennifer L Simpson; Steven L Wechsler
Journal:  Curr Eye Res       Date:  2015-09-23       Impact factor: 2.424

5.  Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocular Herpesvirus Infection.

Authors:  Ruchi Srivastava; Arif A Khan; Sumit Garg; Sabrina A Syed; Julie N Furness; Hawa Vahed; Tiffany Pham; Howard T Yu; Anthony B Nesburn; Lbachir BenMohamed
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

Review 6.  Application of our understanding of pathogenesis of herpetic stromal keratitis for novel therapy.

Authors:  Naveen K Rajasagi; Barry T Rouse
Journal:  Microbes Infect       Date:  2018-01-09       Impact factor: 2.700

Review 7.  Corneal lymphangiogenesis in herpetic stromal keratitis.

Authors:  Paul J Park; Michael Chang; Nitin Garg; Jimmy Zhu; Jin-Hong Chang; Deepak Shukla
Journal:  Surv Ophthalmol       Date:  2014-06-10       Impact factor: 6.048

8.  CXCL10/CXCR3-Dependent Mobilization of Herpes Simplex Virus-Specific CD8+ TEM and CD8+ TRM Cells within Infected Tissues Allows Efficient Protection against Recurrent Herpesvirus Infection and Disease.

Authors:  Ruchi Srivastava; Arif A Khan; Sravya Chilukuri; Sabrina A Syed; Tien T Tran; Julie Furness; Elmostafa Bahraoui; Lbachir BenMohamed
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

Review 9.  Type I interferon and lymphangiogenesis in the HSV-1 infected cornea - are they beneficial to the host?

Authors:  Katie Bryant-Hudson; Christopher D Conrady; Daniel J J Carr
Journal:  Prog Retin Eye Res       Date:  2013-07-19       Impact factor: 21.198

10.  Asymptomatic HLA-A*02:01-restricted epitopes from herpes simplex virus glycoprotein B preferentially recall polyfunctional CD8+ T cells from seropositive asymptomatic individuals and protect HLA transgenic mice against ocular herpes.

Authors:  Xavier Dervillez; Huma Qureshi; Aziz A Chentoufi; Arif A Khan; Elizabeth Kritzer; David C Yu; Oscar R Diaz; Chetan Gottimukkala; Mina Kalantari; Maria C Villacres; Vanessa M Scarfone; Denise M McKinney; John Sidney; Alessandro Sette; Anthony B Nesburn; Steven L Wechsler; Lbachir BenMohamed
Journal:  J Immunol       Date:  2013-10-07       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.